Similarly, preservation of insulin sensitivity through PTP1B deletion or pharmacological inhibition of PTP1B protects against obesity- [8], hypertension- [9] and heart failure- [10] induced endothelial dysfunction. The gene discussed is PTPN1; the disease is obesity due to melanocortin 4 receptor deficiency.